2315.HK · BIOCYTOGEN-B
Hong Kong · RS rating 62 · As of 2026-10-14
| Price | 53.15 HKD |
|---|---|
| 1-day change | -4.8% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 23 / 56 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 28 / 39 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +33.3% |
| Market cap (USD) | $3.9B |